NANGIOTX
NangioTx, Inc. has developed a proprietary injectable drug, V-10, that creates new blood vessels for the treatment of peripheral artery disease (PAD), for which there is currently no FDA-approved therapy. PAD is characterized by poor blood flow to the legs, which leads to tissue damage and ultimately limb amputation/death. V-10’s activity is localized, minimally invasive, reverses the disease, and is cost-efficient. We have secured IP and have "freedom to operate."
NANGIOTX
Industry:
Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.nangiotx.com
Total Employee:
11+
Status:
Active
Contact:
1 646-883-1386
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Office 365 Mail Google Apps For Business GoDaddy DNS
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - NangioTx
More informations about "NangioTx"
NangioTx - Crunchbase Company Profile & Funding
NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration. View contacts for NangioTx to access new leads and connect with decision …See details»
NangioTx Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for NangioTx. Use the PitchBook Platform to explore the full profile.See details»
NangioTx - LinkedIn
NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration. Blood-vessel formation induced by our patent-pending V-10 peptide restores blood flow,...See details»
NangioTx Company Profile | Management and Employees List
NangioTx is a Houston-based company developing a platform regenerative technology to engineer tissue by returning blood flow to dying organs. Reduced blood flow (ischemia) to the …See details»
NangioTx - Overview, News & Similar companies | ZoomInfo.com
NangioTx contact info: Phone number: (678) 613-1386 Website: www.nangiotx.com What does NangioTx do? NangioTx is a Houston-based company developing a platform regenerative …See details»
NANGIOTX INC Company Profile | Newark, NJ - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NANGIOTX INC of Newark, NJ. Get the latest business insights from Dun & Bradstreet.See details»
NangioTx - Products, Competitors, Financials, Employees, …
NangioTx is a pharmaceutical company developing peptide drug formulations for blood vessel growth in chronic peripheral vascular disease. Use the CB Insights Platform to explore …See details»
NangioTx - VentureRadar
Website: http://nangiotx.com. NangioTx, Inc. has developed a proprietary injectable drug, V-10, that creates new blood vessels for the treatment of peripheral artery disease (PAD), for which …See details»
NangioTx - Funding, Financials, Valuation & Investors - Crunchbase
May 19, 2016 · NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration.See details»
NangioTx - Crunchbase
NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration.See details»
NangioTx Inc. | New York, NY, US Startup - gust.com
Find investment information and connect with NangioTx Inc., a New York, NY, US based Nanotechnology startup.See details»
NANGIOTX INC | SBIR.gov
Project Summary / Abstract NangioTx has developed a patented technology for promoting neovascularization in ischemic tissues. Its lead compound is a 33-amino-acid pro-angiogenic …See details»
Pitch | NangioTx Inc
NangioTx’s flagship product is an injectable drug, V-10, that helps create new blood vessels to treat root canals. NangioTx' injectable hydrogel creates a tissue regenerative matrix. …See details»
NangioTx, Inc. Wins Mid-Atlantic Bio Angels 1st Pitch Life
Mar 7, 2016 · NangioTx is a Houston-based drug development company developing a novel drug promoting growth of new blood vessels in the muscles of patients with peripheral artery …See details»
NANGIOTX - AngelMD
NangioTx, Inc. is a seed-stage biotechnology company whose flagship product is an injectable drug, V-11, that helps create new blood vessels to regenerate tissue. We’re going after root …See details»
NangioTx - Contacts, Employees, Board Members, Advisors
NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration.See details»
NangioTx, Inc.Wins Mid-Atlantic Bio Angels’ “Best of the
Dec 13, 2016 · NangioTx is a Houston-based drug development company developing a novel drug that promotes the growth of new blood vessels in the muscles of patients with peripheral …See details»
NangioTx, Inc. Named “Best in Show” at Mid-Atlantic Bio Angels …
Mar 10, 2016 · NangioTx is a Houston-based drug development company developing a novel drug promoting growth of new blood vessels in the muscles of patients with peripheral artery …See details»
NangioTx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration.See details»
Ali Stroker - Wikipedia
Ali Stroker grew up in New Jersey with her parents, Jody and Jim Stroker, as well as an older brother, Jake. At the age of two, Stroker and her brother were in a car accident that resulted in …See details»